Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1953 3
1956 1
1959 1
1964 1
1965 5
1966 7
1967 2
1968 4
1969 11
1970 8
1971 3
1972 1
1973 1
1974 1
1976 4
1977 3
1978 4
1979 2
1980 3
1981 7
1982 5
1983 2
1984 2
1985 3
1986 5
1987 4
1988 3
1989 6
1990 7
1991 4
1992 8
1993 10
1994 12
1995 13
1996 16
1997 18
1998 18
1999 14
2000 10
2001 11
2002 15
2003 10
2004 11
2005 11
2006 12
2007 20
2008 14
2009 14
2010 17
2011 10
2012 10
2013 9
2014 19
2015 11
2016 14
2017 13
2018 17
2019 16
2020 20
2021 29
2022 45
Text availability
Article attribute
Article type
Publication date

Search Results

548 results
Results by year
Filters applied: . Clear all
Page 1
Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights.
Kushima I, Aleksic B, Nakatochi M, Shimamura T, Okada T, Uno Y, Morikawa M, Ishizuka K, Shiino T, Kimura H, Arioka Y, Yoshimi A, Takasaki Y, Yu Y, Nakamura Y, Yamamoto M, Iidaka T, Iritani S, Inada T, Ogawa N, Shishido E, Torii Y, Kawano N, Omura Y, Yoshikawa T, Uchiyama T, Yamamoto T, Ikeda M, Hashimoto R, Yamamori H, Yasuda Y, Someya T, Watanabe Y, Egawa J, Nunokawa A, Itokawa M, Arai M, Miyashita M, Kobori A, Suzuki M, Takahashi T, Usami M, Kodaira M, Watanabe K, Sasaki T, Kuwabara H, Tochigi M, Nishimura F, Yamasue H, Eriguchi Y, Benner S, Kojima M, Yassin W, Munesue T, Yokoyama S, Kimura R, Funabiki Y, Kosaka H, Ishitobi M, Ohmori T, Numata S, Yoshikawa T, Toyota T, Yamakawa K, Suzuki T, Inoue Y, Nakaoka K, Goto YI, Inagaki M, Hashimoto N, Kusumi I, Son S, Murai T, Ikegame T, Okada N, Kasai K, Kunimoto S, Mori D, Iwata N, Ozaki N. Kushima I, et al. Among authors: kosaka h. Cell Rep. 2018 Sep 11;24(11):2838-2856. doi: 10.1016/j.celrep.2018.08.022. Cell Rep. 2018. PMID: 30208311 Free article.
Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial.
Yamasue H, Okada T, Munesue T, Kuroda M, Fujioka T, Uno Y, Matsumoto K, Kuwabara H, Mori D, Okamoto Y, Yoshimura Y, Kawakubo Y, Arioka Y, Kojima M, Yuhi T, Owada K, Yassin W, Kushima I, Benner S, Ogawa N, Eriguchi Y, Kawano N, Uemura Y, Yamamoto M, Kano Y, Kasai K, Higashida H, Ozaki N, Kosaka H. Yamasue H, et al. Among authors: kosaka h. Mol Psychiatry. 2020 Aug;25(8):1849-1858. doi: 10.1038/s41380-018-0097-2. Epub 2018 Jun 29. Mol Psychiatry. 2020. PMID: 29955161 Clinical Trial.
Does first-line treatment have prognostic impact for unresectable HCC?-Atezolizumab plus bevacizumab versus lenvatinib.
Hiraoka A, Kumada T, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Naganuma A, Kosaka H, Shibata H, Aoki T, Tanaka T, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Joko K, Iijima H, Kaibori M, Hiasa Y, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Hiraoka A, et al. Among authors: kosaka h. Cancer Med. 2022 Jun 3. doi: 10.1002/cam4.4854. Online ahead of print. Cancer Med. 2022. PMID: 35666040 Free article.
Ischemic fasciitis.
Komatsu M, Kosaka H, Yoshizaki Y, Ueda M. Komatsu M, et al. Among authors: kosaka h. J Dermatol. 2010 Oct;37(10):934-6. doi: 10.1111/j.1346-8138.2010.00912.x. J Dermatol. 2010. PMID: 20860751 No abstract available.
Near-Infrared Fluorescence Imaging and Photodynamic Therapy for Liver Tumors.
Kaibori M, Kosaka H, Matsui K, Ishizaki M, Matsushima H, Tsuda T, Hishikawa H, Okumura T, Sekimoto M. Kaibori M, et al. Among authors: kosaka h. Front Oncol. 2021 Feb 25;11:638327. doi: 10.3389/fonc.2021.638327. eCollection 2021. Front Oncol. 2021. PMID: 33718233 Free PMC article. Review.
[Calcitonin (CT)].
Kosaka H, Morii H. Kosaka H, et al. Nihon Rinsho. 1995 Mar;53 Su Pt 2:401-3. Nihon Rinsho. 1995. PMID: 8753265 Review. Japanese. No abstract available.
Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child-Pugh class A or B liver function in real-world clinical practice.
Tanaka T, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Naganuma A, Kosaka H, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Joko K, Iijima H, Kaibori M, Hiasa Y, Kudo M, Kumada T; Real-life Practice Experts for HCC (RELPEC) Study Group; HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Tanaka T, et al. Among authors: kosaka h. Hepatol Res. 2022 Sep;52(9):773-783. doi: 10.1111/hepr.13797. Epub 2022 Jun 11. Hepatol Res. 2022. PMID: 35633504
548 results